Using a few zaps of electricity to the skin, researchers can stop bacterial infections without using any drugs. For the first time, researchers designed a skin patch that uses imperceptible electric currents to control microbes.
Lilly strikes deal with QurAlis for preclinical ALS candidate – Pharmaceutical Technology
Eli Lilly will pay QurAlis a $45m upfront payment for QRL-204, a preclinical ALS treatment. Credit: JHVEPhoto via Shutterstock. Eli Lilly is adding another asset